{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:12:44Z","timestamp":1781835164228,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jneuroim.2009.11.013","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T04:11:24Z","timestamp":1259986284000},"page":"100-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Unmasking of PML by HAART: Unusual clinical features and the role of IRIS"],"prefix":"10.1016","volume":"219","author":[{"given":"Navdeesh","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Allen","family":"McCutchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.11.013_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11940-008-0019-8","article-title":"Progressive multifocal leukoencephalopathy","volume":"10","author":"Aksamit","year":"2008","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1212\/WNL.55.8.1194","article-title":"AIDS-related focal brain lesions in the era of highly active antiretroviral therapy","volume":"55","author":"Ammassari","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13550280390195388","article-title":"Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA)","volume":"9","author":"Antinori","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/374048","article-title":"Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy","volume":"36","author":"Berenguer","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib5","first-page":"1737","article-title":"Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein","volume":"5","author":"Chowdhury","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199809173391216","article-title":"Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy","volume":"339","author":"Cinque","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/13550280152537247","article-title":"The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy","volume":"7","author":"Cinque","year":"2001","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13550280390195351","article-title":"The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature","volume":"9","author":"Cinque","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy in HIV-1 infection","volume":"9","author":"Cinque","year":"2009","journal-title":"Lancet, Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00023210-200317120-00002","article-title":"Opportunistic infections of the CNS in patients with AIDS: diagnosis and management","volume":"17","author":"Collazos","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00365540600951341","article-title":"Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy","volume":"39","author":"D'Amico","year":"2007","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib12","first-page":"1937","article-title":"Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy","volume":"12","author":"De Luca","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/01.WNL.0000081306.86961.33","article-title":"Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual","volume":"61","author":"Du Pasquier","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/524877","article-title":"5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease","volume":"197","author":"Focosi","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00688566","article-title":"Progressive multifocal leucoencephalopathy. Observation with predominant pontocerebellar lesions and association with congenital immune deficiency","volume":"38","author":"Gagne","year":"1977","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jnen\/62.5.429","article-title":"The changing pattern of HIV neuropathology in the HAART era","volume":"62","author":"Gray","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13550280500511741","article-title":"Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment","volume":"11","author":"Gray","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib19","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.41.11.1733","article-title":"Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data","volume":"41","author":"Holman","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00415-008-0731-z","article-title":"Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy","volume":"255","author":"Kraemer","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.410170407","article-title":"Progressive multifocal leukoencephalopathy: clinical and radiographic features","volume":"17","author":"Krupp","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib22","first-page":"189","article-title":"Progressive multifocal leukoencephalopathy (PML) in AIDS: morphological and topographical characteristics","volume":"75","author":"Kuchelmeister","year":"1991","journal-title":"Verh. Dtsch. Ges. Pathol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13550280500513846","article-title":"Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era","volume":"11","author":"Manzardo","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/00002030-199818000-00016","article-title":"Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy","volume":"12","author":"Miralles","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/00002030-200109280-00028","article-title":"Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy","volume":"15","author":"Miralles","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib26","first-page":"91","article-title":"Pathomorphological variations of the AIDS-associated progressive multifocal leukoencephalopathy","volume":"38","author":"Mossakowski","year":"2000","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib27","first-page":"1896","article-title":"Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team","volume":"20","author":"Post","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome. Emergence of a unique syndrome syndrome during HAART","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00147-004-0779-3","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"17","author":"Shitrit","year":"2005","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","article-title":"PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids","volume":"72","author":"Tan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1086\/514762","article-title":"Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy","volume":"28","author":"Tantisiriwat","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.61.6.734","article-title":"The uninvited guest: JC virus infection of neurons in PML","volume":"61","author":"Tyler","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.11.013_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-005-0983-y","article-title":"Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy","volume":"109","author":"Vendrely","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00867351","article-title":"Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature","volume":"240","author":"Von Einsiedel","year":"1993","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/01.qai.0000136093.47316.f3","article-title":"Progressive multifocal leukoencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death","volume":"37","author":"Wyen","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jneuroim.2009.11.013_bib37","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1212\/01.WNL.0000096147.47128.7D","article-title":"Comparison of PCR-amplified JC virus control region sequences from multiple brain regions in PML","volume":"61","author":"Yasuda","year":"2003","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809004779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809004779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:52Z","timestamp":1759047172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809004779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0165572809004779"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.11.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking of PML by HAART: Unusual clinical features and the role of IRIS","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}